IL6 and cancer: Moreover, the expression of complement factors was not upregulated in lung fibroblasts following exposure to cancer cell CM alone, indicating that although tumor-secreted factors upregulated the expression of known inflammatory mediators in lung fibroblasts (IL-1β, IL-6) (Supplementary Fig. 8a), they were not sufficient to trigger activation of complement signaling, at least in vitro.